Skip to main content
Livermore
Livermore
ZHEN

Frazier Management LLC

SEC CIK
0001032165
Latest filing
Nov 14, 2022

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
41
+7 vs. Q2 2021
Portfolio value
$1.25B
+$165.5M (+15.3%) vs. Q2 2021
Filed
Nov 12, 2021
SEC
Holdings of Frazier Management LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
ARQTArcutis Biotherapeutics, Inc.COM8,434,232$201.5M16.1%00.0%UnchangedHistory
PHATPhathom Pharmaceuticals, Inc.COM5,827,415$187.1M15.0%00.0%UnchangedHistory
MIRMMirum Pharmaceuticals, Inc.COM3,566,912$71.1M5.7%00.0%UnchangedHistory
IOVAIovance Biotherapeutics, Inc.COM2,674,299$65.9M5.3%+536,300+25.1%AddedHistory
IMGOImago BioSciences, Inc.COM2,971,274$59.5M4.8%+2,971,274NewHistory
PCVXVaxcyte, Inc.COM2,309,554$58.6M4.7%00.0%UnchangedHistory
Trillium Therapeutics Inc.89620X506COM NEW3,123,107$55.0M4.4%00.0%Unchanged–
GRTSGritstone bio, Inc.COM4,667,242$50.4M4.0%+3,636,364+352.7%AddedHistory
PASGPassage BIO, Inc.COM5,009,219$49.9M4.0%00.0%UnchangedHistory
KRYSKrystal Biotech, Inc.COM771,250$40.3M3.2%−16,626−2.1%ReducedHistory
TARSTarsus Pharmaceuticals, Inc.COM1,417,157$30.5M2.4%00.0%UnchangedHistory
ISEEIVERIC bio, Inc.COM1,838,402$29.9M2.4%−706,098−27.7%ReducedHistory
STROSutro Biopharma, Inc.COM1,468,663$27.7M2.2%+467,242+46.7%AddedHistory
VRDNViridian Therapeutics, Inc.COM1,505,200$24.8M2.0%+1,505,200NewHistory
ANABAnaptysbio, IncCOM899,700$24.4M2.0%00.0%UnchangedHistory
AUTLAutolus Therapeutics plcSPON ADS3,530,657$23.1M1.9%+1,246,691+54.6%AddedHistory
SNDXSyndax Pharmaceuticals IncCOM1,188,135$22.7M1.8%00.0%UnchangedHistory
TYRATyra Biosciences, Inc.COM1,250,000$22.0M1.8%+1,250,000NewHistory
KDNYChinook Therapeutics, Inc.COM1,671,918$21.3M1.7%+571,918+52.0%AddedHistory
ALPNAlpine Immune Sciences, Inc.COM1,771,844$18.9M1.5%−799,606−31.1%ReducedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS442,880$18.4M1.5%+442,880NewHistory
CRNXCrinetics Pharmaceuticals, Inc.COM851,306$17.9M1.4%+851,306NewHistory
SRRASierra Oncology, Inc.COM NEW804,667$17.6M1.4%+601,864+296.8%AddedHistory
Frazier Lifesciences Acqu CoG3710A121UNIT 12/09/20251,501,000$15.1M1.2%00.0%Unchanged–
REPLReplimune Group, Inc.COM491,998$14.6M1.2%+491,998NewHistory
Gracell Biotechnologies Inc38406L103SPONSORED ADS851,638$11.8M0.9%+851,638New–
RGNXREGENXBIO Inc.COM235,809$9.88M0.8%−116,145−33.0%ReducedHistory
AVDLAvadel Pharmaceuticals PLCSPONSORED ADR951,814$9.33M0.7%+373,710+64.6%AddedHistory
MTEMMolecular Templates, Inc.COM1,374,047$9.22M0.7%00.0%UnchangedHistory
ACRSAclaris Therapeutics, Inc.COM408,329$7.35M0.6%+37,596+10.1%AddedHistory
SRRKScholar Rock Holding CorpCOM156,000$5.15M0.4%00.0%UnchangedHistory
IMVTImmunovant, Inc.COM585,759$5.09M0.4%+331,759+130.6%AddedHistory
APTXAptinyx Inc.COM1,883,244$4.41M0.4%00.0%UnchangedHistory
EPZMEpizyme, Inc.COM739,369$3.79M0.3%00.0%UnchangedHistory
ALNAAllena Pharmaceuticals, Inc.COM3,330,373$3.00M0.2%00.0%UnchangedHistory
EPIXESSA Pharma Inc.COM NEW358,346$2.87M0.2%+41,730+13.2%AddedHistory
KALVKalVista Pharmaceuticals, Inc.COM156,807$2.74M0.2%+156,807NewHistory
Bellus Health Inc New07987C204COM NEW433,247$2.65M0.2%−863,496−66.6%Reduced–
GRTXGalera Therapeutics, Inc.COM241,000$1.95M0.2%00.0%UnchangedHistory
Freeline Therapeutics Hldgs35655L107SPONSORED ADS550,000$1.88M0.2%00.0%Unchanged–
Nabriva Therapeutics plcG63637113SHS425,650$507.0K<0.1%00.0%Unchanged–

Sold out since Q2 2021 (1)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Frazier Management LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
Translate Bio, Inc.89374L104COM2,082,789$57.4M5.3%–